Genetic testing company 23andMe made its public debut under the ticker symbol “ME” yesterday, after a merger with a Richard Branson Spac, VG Acquisition Corp. Company founder and CEO Anne Wojcicki told CNBC the company is planning to build a big consumer business off its base of 11 million customers and drug research and development … Continue reading “23andMe Shares Pop as Company Makes its Market Debut”
